// App-Quantinova.ai

P2.099 : Impact of co-morbid amyloid pathology on clinical phenotype of patients with vascular cognitive impairment (P2.099)

Researchers

Presenter

  • David Bergeron

Principal Investigators

  • Niels Prins

  • Colin Groot

  • Anita van Loenhoud

  • Robert Laforce

  • Bart van Berckel

  • Frederic Barkhof

  • Wiesje van der Flier

  • Philip Scheltens

  • Rik Ossenkoppele

Medical Centers

  • VU University Medical Center, Amsterdam, Netherlands

  • VU University Medical Center, Amsterdam, Netherlands

  • Universite Laval, Quebec, QC, Canada

Locations

  • Netherlands

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved